# Program10 Regulatory Readiness Report
**CyberCom Platform — Release 2**  
**Date:** 2026-06-29  
**Classification:** Confidential — Internal Use Only  
**Roles:** CCO, Legal, CMIO, CIO

---

## Executive Summary

CyberCom Platform Release 2 is **architecturally compliant** with the applicable regulatory frameworks for Jordan, Saudi Arabia, UAE, and EU markets. Software-level controls are implemented. Regulatory filing, external audit, and market authorization remain as external actions required before full production launch.

**Software Status:** READY  
**External Filing Status:** PENDING (see External Blockers)

---

## Regulatory Framework Coverage

### 1. Data Protection & Privacy

| Framework | Status | Evidence | Gap |
|-----------|--------|----------|-----|
| Jordan Personal Data Protection Law 2023 | ARCHITECTURE READY | Multi-tenant isolation, AuditLog, GDPR-class controls | DPO appointment, filing |
| Saudi PDPL (Personal Data Protection Law) | ARCHITECTURE READY | Encryption at rest/transit, consent capture, retention policies | NDMO registration |
| UAE Data Protection (DIFC/ADGM) | ARCHITECTURE READY | Data residency config (home_region field), cross-border transfer controls | Market-specific filing |
| GDPR (EU customers) | ARCHITECTURE READY | ComplianceProfile model, AuditRetentionPolicy, LegalHold | DPA + DPO required |

**Key Architecture Controls:**
- `AuditRetentionPolicy`: per-tenant, per-category retention schedules (hot/warm/cold)
- `LegalHold`: freeze audit records from deletion during litigation
- `DataClassification` enum: `public / internal / confidential / restricted / phi / pii / financial / government_sensitive`
- `ComplianceFrameworkCode`: HIPAA, GDPR, PDPL, UAE_DP, JORDAN_DP, SOC2, ISO27001, NCA_ECC
- `EvidenceRecord` + `EvidencePackage`: chain-of-custody evidence management

### 2. Healthcare IT Standards

| Standard | Status | Evidence |
|----------|--------|----------|
| IEC 62304 (Medical Device SW Lifecycle) | PARTIAL | SDLC documented; formal classification not yet filed |
| HL7 FHIR R4 | IMPLEMENTED | `/fhir/R4/` endpoint; CapabilityStatement, Patient, Observation, Condition, MedicationRequest, Bundle |
| HL7 v2 | IMPLEMENTED | ADT^A01, ADT^A03, ORU^R01, ORM^O01 supported |
| DICOM | IMPLEMENTED | MWL push, DICOM store, PACS integration via Mirth |
| ICD-11 | IMPLEMENTED | TerminologyService + TerminologyAuditLog; lookup, validate, expand |
| SNOMED CT | IMPLEMENTED | Substance codes, clinical status codes |
| LOINC | IMPLEMENTED | Lab test codes (e.g., 2160-0 Creatinine) |
| ICF | IMPLEMENTED | Functional classification support |
| RxNorm | IMPLEMENTED | Drug codes in InteractionRule, Prescription |

### 3. Information Security Standards

| Standard | Status | Evidence |
|----------|--------|----------|
| ISO 27001 | ARCHITECTURE READY | ComplianceProfile, ComplianceRule, ComplianceViolation, ComplianceAssessment models |
| SOC 2 Type II | PLANNED Q4 2026 | Pre-controls implemented; audit not yet initiated |
| NCA ECC (Saudi) | ARCHITECTURE READY | Encryption, access control, audit, incident response architecture |
| PCI DSS | ARCHITECTURE READY | If payment module added (not in current scope) |

### 4. Clinical Governance

| Requirement | Status | Evidence |
|-------------|--------|----------|
| Advisory-only AI | IMPLEMENTED | `GuardrailPolicy`, `InferenceLog.safety_verdict`, no AI auto-approval path |
| Drug interaction mandatory alerting | IMPLEMENTED | `InteractionSeverity.auto_block_dispensing = True` for contraindicated |
| Clinical audit trail | IMPLEMENTED | `AuditEvent.category = "clinical"`, purpose_of_use field |
| Break glass dual-approval | IMPLEMENTED | `BreakGlassAccess.second_approver`, mandatory `justification` |
| Critical value mandatory notification | IMPLEMENTED | `is_critical=True` → Celery notification task |

---

## Regulatory Gaps (External Actions Required)

| Gap | Market | Priority | Owner |
|-----|--------|----------|-------|
| Jordan MOH product registration | JO | HIGH | CCO |
| Saudi SFDA pre-market notification | SA | HIGH | CCO |
| Saudi NDMO privacy registration | SA | HIGH | Legal |
| UAE MOHAP / CBUAE filing | UAE | MEDIUM | CCO |
| EU CE marking (if MDD/MDR applies) | EU | MEDIUM | Quality |
| IEC 62304 formal lifecycle package | All | HIGH | Quality Manager |
| DPO appointment (GDPR) | EU | MEDIUM | Legal |
| Clinical workflow validation by licensed clinicians | All | HIGH | CMIO |

---

## Compliance Posture by Market

| Market | Regulatory Status | Software Controls | External Blockers |
|--------|-------------------|-------------------|-------------------|
| Jordan | PRE-FILING | ✅ READY | MOH registration |
| Saudi Arabia | PRE-FILING | ✅ READY | SFDA + NDMO filing |
| UAE | PRE-FILING | ✅ READY | MOHAP notification |
| EU | PRE-FILING | ✅ READY | DPA + GDPR DPO |
| USA | N/A (not targeted) | HIPAA arch. ready | BAA per customer |

---

## Conclusion

**REGULATORY STATUS: ARCHITECTURE READY — EXTERNAL ACTIONS PENDING**

The software implements the required regulatory architecture. Market-specific filing, external clinical validation, and regulatory authority notifications are required before full commercial launch. Pilot deployment can proceed under hypercare with existing software controls in place.
